Lung Cancer Clinical Trial

A Registry for Patients With Multifocal Ground Glass Opacities (GGOs)

Summary

The purpose of this registry study is to actively monitor people with GGOs and collect information about them, so that investigators can learn more about these lesions and about the risk of developing lung cancer in study participants whose GGOs are being monitored in the active surveillance program.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age greater than 18 years
Have two or more GGOs on initial CT imaging
GGOs must be measure ≤3.0 cm and ≥0.6 cm in the greatest dimension
GGOs must be greater than half ground glass

A biopsy is not necessary for inclusion in the trial. Biopsy of a GGO, even with a diagnosis of adenocarcinoma, does not necessarily preclude enrollment in this surveillance protocol. In other words, patients with a diagnosis of adenocarcinoma are still eligible, at the discretion of the clinician and/or investigator, if they meet the above criteria.

Exclusion Criteria:

Patients who are actively undergoing lung cancer treatment or have a history of lung cancer, except for cases of completely resected pathologic stage IA nonsmall cell lung cancer (NSCLC). Patients with stage IA NSCLC and multiple GGOs can enroll in this active surveillance protocol after complete resection of the NSCLC and confirmation of stage on final pathologic assessment.
The presence of any solid lesion ≥0.6 cm suspicious for malignancy.
Patients who are actively undergoing treatment for other malignancies

Study is for people with:

Lung Cancer

Estimated Enrollment:

330

Study ID:

NCT03802981

Recruitment Status:

Recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 27 Locations for this study

See Locations Near You

Stanford University Medical Center (Data collection only)
Stanford California, 94305, United States More Info
Douglas Liou, MD
Contact
650-498-6000
Hartford Healthcare
Hartford Connecticut, 06102, United States More Info
Tejal Shah, MD
Contact
860-827-2710
Rush University Medical Center (Data collection only)
Chicago Illinois, 60601, United States More Info
Christopher Seder, MD
Contact
312-738-3732
Massachusetts General Hospital Cancer Center
Boston Massachusetts, 02114, United States More Info
Michael Lanuti, MD
Contact
617-726-6751
Brigham and Women's Hospital
Boston Massachusetts, 02115, United States More Info
Matthew Rochefort, MD
Contact
844-294-5864
University of Michigan
Ann Arbor Michigan, 48109, United States More Info
Jules Lin, MD
Contact
734-936-8857
Mayo Clinic
Rochester Minnesota, 55905, United States More Info
Shanda Blackman, MD,MPH
Contact
507-538-3270
George Washington University School of Medicine
Saint Louis Missouri, 63110, United States More Info
Benjamin S. Kozower, MD
Contact
314-362-8089
Washington University School of Medicine
Saint Louis Missouri, 63110, United States More Info
Benjamin Kozower, MD
Contact
314-362-8089
Memorial Sloan Kettering Basking Ridge
Basking Ridge New Jersey, 07920, United States More Info
James Huang, MD
Contact
212-639-2530
Memorial Sloan Kettering Monmouth
Middletown New Jersey, 07748, United States More Info
James Huang, MD
Contact
212-639-2530
Memorial Sloan Kettering Bergen
Montvale New Jersey, 07645, United States More Info
James Huang, MD
Contact
212-639-2530
Roswell Park Cancer Institute (Data Collection Only)
Buffalo New York, 14263, United States More Info
Todd Demmy, MD, FACS
Contact
716-845-2300
Memorial Sloan Kettering Commack
Commack New York, 11725, United States More Info
James Huang, MD
Contact
212-639-2530
Memorial Sloan Kettering Westchester
Harrison New York, 10604, United States More Info
James Huang, MD
Contact
212-639-2530
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States More Info
James Huang, MD
Contact
212-639-2530
David R. Jones, MD
Contact
212-639-6428
James Huang, MD
Principal Investigator
Memorial Sloan Kettering Nassau
Uniondale New York, 11553, United States More Info
James Huang, MD
Contact
212-639-2530
Duke University Medical Center
Durham North Carolina, 27701, United States More Info
Betty Tong, MD
Contact
919-613-1909
Lehigh Valley Health Network
Allentown Pennsylvania, 18103, United States More Info
C. Gerard Petersen, MD
Contact
888-402-5846
University of Pennsylvania (Data Collection Only)
Philadelphia Pennsylvania, 19104, United States More Info
Doraid Jarrar, MD
Contact
215-662-9195
Thomas Jefferson University Hospital
Philadelphia Pennsylvania, 19107, United States More Info
Nathaniel Evans III, MD
Contact
[email protected]
Fox Chase Cancer Center
Philadelphia Pennsylvania, 19111, United States More Info
Stacey Su, MD
Contact
888-369-2427
Allegheny-Singer Research Institute
Pittsburgh Pennsylvania, 15212, United States More Info
Benny Weksler, MD
Contact
412-359-6137
University of Pittsburgh Medical Center
Pittsburgh Pennsylvania, 15213, United States More Info
Arjun Pennathur, MD
Contact
412-648-6271
MD Anderson Cancer Center
Houston Texas, 77030, United States More Info
Mara Antonoff, MD
Contact
[email protected]
Baylor University Medical Center
Houston Texas, 77030, United States More Info
Philip Carrott Jr., MD
Contact
713-798-6376
McMaster University (Data Collection Only)
Hamilton Ontario, L8N 3, Canada More Info
Yaron Shargall, MD, BSc, FRCSC, FCCP
Contact
(905) 522-1155 x33229
University Health Network
Toronto Ontario, M5G 2, Canada More Info
Laura Donahoe, MD
Contact
[email protected]
Centre Hospitalier de l'Université de Montreal
Montréal Quebec, H2L 4, Canada More Info
Moishe Liberman, MD. PhD
Contact
514-890-8000, ext: 26832

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

330

Study ID:

NCT03802981

Recruitment Status:

Recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.